The short-term risk of stroke after transient ischemic attack (TIA) is about 10% to 20% in the first 3 months, with much of the risk front-loaded in the first week. Unfortunately, little is known about the best therapies for hyperacute stroke prevention after TIA. A recent trial referred to by the acronym MATCH (for Management of Atherothrombosis With Clopidogrel in High-risk Patients With Recent Transient Ischemic Attack or Ischemic Stroke) provides hypothesis-generating data to suggest that...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Stroke prevention. MATCHing therapy to the patient with TIA.
If you are the owner of this record, you can report an update to it here: Report update to this record